Adaptix signs MOU with IBEX on bone health
17 November 2026
Avingtrans plc
("Avingtrans", the "Company", or the "Group")
Adaptix signs MOU with IBEX on bone health
Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, is pleased to announce that its medical imaging subsidiary, Adaptix Ltd (“Adaptix”), has signed a Memorandum of Understanding (“MOU”) with IBEX Innovations Ltd (“IBEX”) to integrate IBEX’s CorteX bone health software into Adaptix’s FDA 510(k) cleared and CE marked Ortho 3D X-ray Imaging System (the “Ortho350”).
By integrating CorteX into the Ortho350 portable 3D X-ray imaging platform, the two companies aim to provide patients with a pay-per-scan bone density report at the point of care (“POC”), making bone density assessment widely available. Preliminary surveys indicated that this would be strongly welcomed by patients if offered on a cash-pay basis alongside other routine clinical assessments.
CorteX outputs the same recognised clinical biomarkers as dual-energy X-ray absorptiometry (“DXA”), with a low T-score at the wrist being an established indicator of elevated fracture risk and general bone loss, a key concern, particularly for women approaching the menopause. The CorteX software is FDA 510(k) submission pending and is not yet available for commercial distribution or sale in the United States.
The Ortho350 is a portable Digital Tomosynthesis system designed to provide high-resolution, low-dose 3D imaging for musculoskeletal diagnostics at the POC. The system addresses the limitations of traditional 2D X-ray imaging while offering a more accessible alternative to full CT scans.
Dr Paul Scott, Chief Executive Officer of IBEX, commented:
“Together we are bringing bone health assessment to the physician’s desktop. This is transformational for patients who often only become aware of a problem once a fracture has occurred. Making bone health assessment fast, easy and widely accessible is the missing ingredient to support clinicians in stopping osteoporosis in its tracks.”
Stuart Gall, Chief Executive Officer of the Medical and Industrial Imaging Division at Avingtrans, commented:
“We are excited to be taking this first step with IBEX and working with them to bring their excellent bone density test to market on the Ortho350 imaging platform. We have asked them to join our exhibition stand at RSNA 2026 in Chicago and would welcome any imaging centres, hospitals or interested OEMs to visit us on Stand 3159, South Hall, Level 3.”
- ENDS -
Enquiries:
|
Avingtrans plc |
013 5469 2391 |
|
Roger McDowell, Chairman Steve McQuillan, Chief Executive Officer Stephen King, Chief Financial Officer
|
|
|
Singer Capital Markets (Nominated Adviser and Broker) |
020 7496 3000 |
|
Shaun Dobson Alex Bond Daniel Ingram |
|
|
IFC Advisory (Financial PR) |
020 3934 6630 |
|
Graham Herring Tim Metcalfe Zach Cohen |
|
About Avingtrans plc:
Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide.
Business units
|
Hayward Tyler - Luton, East Kilbride UK, USA, China and India Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments. Energy Steel, Inc - Rochester Hills, Michigan, USA Provider of custom fabrications for the nuclear industry, specialising in: OEM parts obsolescence; custom fabrications; engineering design solutions; product refurbishment; on-site technical support. Stainless Metalcraft Ltd - Chatteris, UK Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems. Booth Industries - Bolton, UK Designs, manufactures, installs and services doors and walls which can be tailored to be: blast and explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above. Ormandy Group - Bradford, UK Design, manufacturers and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products. Slack & Parr - Kegworth, UK, USA & China Design, manufacture and servicing of high-precision gear metering pumps, hydraulics flow dividers and industrial pumps. Composite Products Ltd - Buckingham, UK Centre for composite technology, parts and assemblies, serving customers in industrial markets. Adaptix Ltd - Oxford, UK Adaptix has developed novel 3D X-ray for Orthopaedic and Veterinary applications amongst others. Commercialisation of this system (and others) is on-going. Magnetica Ltd - Brisbane, Australia Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going. Magnetica's structure now includes two other business units: Scientific Magnetics - Abingdon, UK Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments. Tecmag Inc - Houston, USA Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems. |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE